FY02/2019 Q2 Results Earnings Release Presentation
2018.09.28PDF( 62KB)
Notification of application for manufacturing and marketing approval of HP-3000 (Transdermal, Parkinson's disease treatment patch) in Japan
FY02/2019 Q1 Results Earnings Release Presentation
2018.07.02PDF( 64KB)
Notification of approval of supplemental new drug application (NDA) for the addition of a new 0.5mg dose of the transdermal, pain management patch FENTOS® TAPE (development code: HFT-290)
Salonpas Named the World's No.1 OTC Topical Analgesic Patch Brand for the Second Consecutive Year